ANTHONY RAINERI: Open Payments
NPI 1205386430 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,277 in 99 payments from 14 companies in 2025. Trend: 2023 $2,642 · 2024 $3,830 · 2025 $2,277
Food & beverage: $2,161Education: $116
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $562 |
| Janssen Biotech, Inc. | 8 | $461 |
| Regeneron Healthcare Solutions, Inc. | 7 | $301 |
| UCB, Inc. | 19 | $293 |
| Organon LLC | 13 | $233 |
| GENZYME CORPORATION | 3 | $94 |
| Lilly USA, LLC | 3 | $70 |
| Amgen Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| LEO Pharma Inc. | 3 | $48 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, RINVOQ, VTAMA, OTEZLA, ANZUPGO.
Industry payments across PA — which companies pay providers there.
